Prospective study confirms oxandrolone-associated improvement in height in growth hormone-treated adolescent girls with Turner syndrome.

@article{Zeger2011ProspectiveSC,
  title={Prospective study confirms oxandrolone-associated improvement in height in growth hormone-treated adolescent girls with Turner syndrome.},
  author={Martha Dechert Zeger and Kavita A. Shah and Karen Kowal and Gordon B. Cutler and Harvey Kushner and Judith Levine Ross},
  journal={Hormone research in paediatrics},
  year={2011},
  volume={75 1},
  pages={38-46}
}
BACKGROUND/AIMS Untreated girls with Turner syndrome (TS) have growth failure, and adult height is, on average, 20 cm less than predicted height. Treatment with growth hormone (GH) is now standard of care. The objective of this study was to investigate the benefit of adding oxandrolone (Ox) to GH in a long-term, randomized, placebo (Pl)-controlled prospective trial to near adult height in TS. METHODS prospective, randomized, Pl-controlled study: 76 girls with TS (ages 10-14.9 years) were… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 26 references

Efficacy and safety of oxan - drolone in growth hormone - treated girls with Turner syndrome

LA Menke, TC Sas, +3 authors RJ Odink
J Clin Endocrinol Metab • 2010

Similar Papers

Loading similar papers…